HomeCompareAATGF vs PFE

AATGF vs PFE: Dividend Comparison 2026

AATGF yields 4444.44% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AATGF wins by $19857738408180.43M in total portfolio value
10 years
AATGF
AATGF
● Live price
4444.44%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19857738408180.48M
Annual income
$19,016,069,933,146,186,000.00
Full AATGF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — AATGF vs PFE

📍 AATGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAATGFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AATGF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AATGF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AATGF
Annual income on $10K today (after 15% tax)
$377,777.78/yr
After 10yr DRIP, annual income (after tax)
$16,163,659,443,174,257,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, AATGF beats the other by $16,163,659,443,174,234,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AATGF + PFE for your $10,000?

AATGF: 50%PFE: 50%
100% PFE50/50100% AATGF
Portfolio after 10yr
$9928869204090.26M
Annual income
$9,508,034,966,573,105,000.00/yr
Blended yield
95.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

AATGF
No analyst data
Altman Z
-93.7
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AATGF buys
0
PFE buys
0
No recent congressional trades found for AATGF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAATGFPFE
Forward yield4444.44%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$19857738408180.48M$49.6K
Annual income after 10y$19,016,069,933,146,186,000.00$26,258.71
Total dividends collected$19800558376185.16M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AATGF vs PFE ($10,000, DRIP)

YearAATGF PortfolioAATGF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$455,144$444,444.44$9,153$693.39+$446.0KAATGF
2$19,392,277$18,905,272.87$8,593$849.25+$19.38MAATGF
3$773,548,232$752,798,494.96$8,336$1,066.78+$773.54MAATGF
4$28,891,953,466$28,064,256,857.57$8,437$1,384.80+$28891.95MAATGF
5$1,010,538,077,568$979,623,687,360.21$9,013$1,875.40+$1010538.07MAATGF
6$33,103,483,882,921$32,022,208,139,922.89$10,306$2,680.72+$33103483.87MAATGF
7$1,015,787,352,937,823$980,366,625,183,097.90$12,820$4,101.38+$1015787352.93MAATGF
8$29,201,617,438,828,424$28,114,724,971,184,950.00$17,673$6,826.70+$29201617438.81MAATGF
9$786,606,051,433,916,900$755,360,320,774,370,600.00$27,543$12,591.86+$786606051433.89MAATGF
10$19,857,738,408,180,478,000$19,016,069,933,146,186,000.00$49,560$26,258.71+$19857738408180.43MAATGF

AATGF vs PFE: Complete Analysis 2026

AATGFStock

ATI Airtest Technologies Inc. manufactures and sells air testing equipment and related services in Canada and the United States. It offers WiFi and EnOcean transmitters; carbon dioxide (CO2) transmitters for control of ventilation in buildings; parking garage ventilation products comprising stand alone gas transmitters, combined sensor/controllers, and custom configured control systems for on/off and variable modulation of fan systems; indoor wall mount dew point transmitters, indoor humidity and temperature transmitters, outside air dew point for economizer control, humidity and dew point probes, and surface condensation switches. The company also provides industrial air velocity, HVAC airflow monitoring, and low airflow/laminar airflow monitoring products; handheld and portable devices; CO2 modules, air velocity probes, humidity elements, humidity and temperature measurement modules and probes, and humidity calibration; sensors/transmitters and ventilation controllers for measuring gases; industrial low dew point; industrial humidity and temp measurement; moisture in oil transmitters and portable moisture in oil measurement; and materials and tools to perform calibrations on various sensors. ATI Airtest Technologies Inc. was incorporated in 1996 and is headquartered in Delta, Canada.

Full AATGF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this AATGF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AATGF vs SCHDAATGF vs JEPIAATGF vs OAATGF vs KOAATGF vs MAINAATGF vs JNJAATGF vs MRKAATGF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.